Table 3.
Overall 5-Year Mortality by Stage Group (Cox regression model)
| Model | Stage II With No Poor Prognostic Features |
Stage II With Any Poor Prognostic Features |
Stage III |
||||||
|---|---|---|---|---|---|---|---|---|---|
| HR | 95% CI | P | HR | 95% CI | P | HR | 95% CI | P | |
| Unadjusted | 0.67 | 0.59 to 0.77 | < .001 | 0.67 | 0.63 to 0.71 | < .001 | 0.48 | 0.46 to 0.5 | < .001 |
| Adjusted for covariates* | 1.05 | 0.9 to 1.22 | .53 | 0.96 | 0.89 to 1.03 | .24 | 0.64 | 0.61 to 0.68 | < .001 |
| Adjusted for covariates* with propensity score weighting | 1.02 | 0.84 to 1.25 | .80 | 1.03 | 0.94 to 1.13 | .47 | 0.64 | 0.6 to 0.67 | < .001 |
Abbreviation: HR, hazard ratio.
*
Covariates: age, sex, ethnicity, marital status, Surveillance, Epidemiology, and End Results registry, residence location, tumor location, diagnosis year, census-tract median household income and education, Hierarchical Condition Categories score, prior-year hospitalizations, 30-day rehospitalizations, in-hospital complications, 30-day oncologist visits.